End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
28,450 KRW | +0.18% | +0.71% | +2.52% |
2023 | Daihan Pharmaceutical Co.,Ltd.(KOSDAQ:A023910) dropped from S&P Global BMI Index | CI |
2023 | Daihan Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
Sales 2024 * | 213B 156M 12.45B | Sales 2025 * | 233B 170M 13.61B | Capitalization | 167B 123M 9.79B |
---|---|---|---|---|---|
Net income 2024 * | 30B 21.99M 1.76B | Net income 2025 * | 33B 24.19M 1.93B | EV / Sales 2024 * | 0.14 x |
Net cash position 2024 * | 138B 101M 8.07B | Net cash position 2025 * | 163B 120M 9.55B | EV / Sales 2025 * | 0.02 x |
P/E ratio 2024 * |
5.54
x | P/E ratio 2025 * |
5.14
x | Employees | 553 |
Yield 2024 * |
2.46% | Yield 2025 * |
2.55% | Free-Float | 59.32% |
1 day | +0.18% | ||
1 week | +0.71% | ||
Current month | +0.53% | ||
1 month | +0.53% | ||
3 months | +0.89% | ||
6 months | +5.57% | ||
Current year | +2.52% |
Managers | Title | Age | Since |
---|---|---|---|
Yoon-Woo Lee
CEO | Chief Executive Officer | 80 | 01/07/69 |
Dong-Il Lee
BRD | Director/Board Member | 71 | 28/02/02 |
Seong-Soo Yoon
AUD | Comptroller/Controller/Auditor | 46 | 23/03/17 |
Members of the board | Title | Age | Since |
---|---|---|---|
Yoon-Woo Lee
CEO | Chief Executive Officer | 80 | 01/07/69 |
Seung-Young Lee
BRD | Director/Board Member | 51 | 28/02/02 |
Dong-Il Lee
BRD | Director/Board Member | 71 | 28/02/02 |
Date | Price | Change | Volume |
---|---|---|---|
02/05/24 | 28,450 | -.--% | 2,874 |
30/04/24 | 28,450 | +0.18% | 5,981 |
29/04/24 | 28,400 | -0.18% | 4,112 |
26/04/24 | 28,450 | +0.53% | 4,760 |
25/04/24 | 28,300 | -0.70% | 3,847 |
End-of-day quote Korea S.E., April 29, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.52% | 121M | |
+20.61% | 43.18B | |
+20.67% | 22.59B | |
+14.56% | 14.56B | |
+13.94% | 13.54B | |
+43.35% | 11.5B | |
-8.37% | 6.93B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+10.21% | 5.36B |
- Stock Market
- Equities
- A023910 Stock